Efficacy Evaluation of the (Serodase 5 mg Tablet) in the Treatment of Inflammation After Third Molar Surgery
Status:
Unknown status
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the efficacy of dose regimen of serratiopeptidase
(serodase 5 mg) as a prospective, randomized, parallel, double blind Placebo- controlled
study.